Compound ID | 313
BP-102
Class: Beta-lactam (cephalosporin, carbacephem)
| Spectrum of activity: | Gram-negative |
| Details of activity: | Demonstrated bacteriocidal effects on both MSSA and MRSA |
| Combined with other compounds: | The addition of tazobactam improved Gram negative activity |
| Institute where first reported: | Blanca Pharmaceuticals; NAEJA Pharmaceutical; SRI International; Ulysses Pharmaceuticals |
| Year first mentioned: | 2005 |
| Highest developmental phase: | Preclinical |
| Development status: | Inactive |
| External links: | |
| Citation: |
AntibioticDB is supported by GARDP.
If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions
The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.